New research has uncovered a novel trick employed by the bacterium Staphylococcus aureus to thwart the immune response, raising hopes that a vaccine that prevents deadly MRSA infections is a little closer on the horizon.
Immunologists from Trinity College Dublin, working with scientists at GSK — one of the world’s largest vaccine manufacturers — discovered the new trick of the troublesome Staphylococcus aureus, which is the causative agent of the infamous “superbug” MRSA.
